• Home
    • Medication Information Library
    • Medication Interactions
    • Medication Identifier
  • Comments
  • Posts
meds watch
CHEST
  • Home
  • Meds-Watch Home
  • Medication Information Library
  • Medication Interactions
  • Medication Identifier
The Medical Letter Online

Human medicines European Public Assessment Report (EPAR): Privigen, human normal immunoglobulin, Revision: 11, Authorised

admin | May 17, 2012 | 0 Comments

Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products

Tags: assessment, Authorised, EPAR, European, human, immunoglobulin, medicines, normal, Privigen, Public, report, Revision

Category: European Medicines Agency

Subscribe

If you enjoyed this article, subscribe to receive more just like it.

Subscribe via RSS Feed

Leave a Reply

Click here to cancel reply.

« Health Canada Advises Caution When Selling or Buying Products at Garage Sales
Current Drug Shortages: Odansetron Injection 2 mg/mL (updated) »

Archives

  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
Poison Help

RSS ASHP – Current Drug Product Shortages

  • Neostigmine Methylsulfate Injection November 1, 2012
    Drug: Neostigmine, Revision Date: Thu, 01 Nov 2012 […]
  • Mepivacaine Injection November 1, 2012
    Drug: Mepivacaine, Revision Date: Thu, 01 Nov 2012 […]
  • Follitropin Beta Injection November 1, 2012
    Drug: Follitropin Beta, Revision Date: Thu, 01 Nov 2012 […]
  • Mafenide Acetate Powder for Topical Solution November 1, 2012
    Drug: Mafenide Acetate, Revision Date: Thu, 01 Nov 2012 […]

RSS ASHP – Resolved Drug Shortages

  • Pancreatic Enzyme Replacement Products containing Lipase, Protease, and Amylase November 2, 2012
    Drug: Pancreatic Enzyme Replacement Products, Revision Date: Fri, 02 Nov 2012 […]
  • Esomeprazole Magnesium Oral Suspension October 26, 2012
    Drug: Esomeprazole, Revision Date: Fri, 26 Oct 2012 […]
  • Belladonna & Opium Suppositories October 15, 2012
    Drug: Belladonna & Opium Suppositories, Revision Date: Mon, 15 Oct 2012 […]
  • Levofloxacin Injection October 12, 2012
    Drug: Levofloxacin Injection, Revision Date: Fri, 12 Oct 2012 […]

RSS ASHP – Drug Products No Longer Available

  • Buprenorphine and Naloxone Tablets October 9, 2012
    Drug: Buprenorphine and Naloxone, Revision Date: Tue, 09 Oct 2012 […]
  • Chloral Hydrate Oral Solution July 2, 2012
    Drug: Chloral Hydrate, Revision Date: Mon, 02 Jul 2012 […]
  • Verapamil Extended Release Tablets June 20, 2012
    Drug: Verapamil, Revision Date: Wed, 20 Jun 2012 […]
  • Epinephrine Metered Dose Inhaler May 24, 2012
    Drug: Epinephrine, Revision Date: Thu, 24 May 2012 […]

Categories

  • European Medicines Agency
  • FDA Drug Info Rounds
  • FDA Drug Shortages
  • Health Canada
  • Latest Medication News
  • MedEffect Canada
  • Medications
  • MedWatch Safety Alerts
  • Nature reviews-Drug Discovery
  • Recalls
  • What's New: Drugs

RSS Latest Medication News

  • Market watch: Upcoming market catalysts in Q4 2012 October 1, 2012 John Tucker
  • Neurodegenerative disease: EPHA4 inhibition rescues neurodegeneration in ALS October 1, 2012 Mariam Faruqi
  • In search of preclinical robustness October 1, 2012 Ian S. Peers
  • Michael Snyder October 1, 2012
  • Economists propose a US$30 billion boost to biomedical R&D October 1, 2012 Asher Mullard
  • Vaccines: Self-amplifying RNA in lipid nanoparticles: a next-generation vaccine? October 1, 2012 Alexandra Flemming
  • Moving from an asthma pipe dream to a pipeline October 1, 2012 Dave Holmes
  • Patent watch October 1, 2012 Charlotte Harrison
  • News in brief October 1, 2012
  • Bacterial proteolytic complexes as therapeutic targets October 1, 2012 Ravikiran M. Raju

Recent Posts

  • Test Your Home for Radon During Lung Cancer Awareness Month
  • News and press releases: European Medicines Agency website unavailable intermittently Saturday 6 October
  • Ameridose Issues Recall of All Products
  • Classic Zi Xiu Tang Bee Pollen Capsules And Ultimate Formula Capsules by Zi Xiu Tang Success: Recall – Undeclared Sibutramine
  • Metabolic disorders: Safe cannabinoid receptor modulators in sight?

Tags

2012 adopted Agency Alert Allergy assessment Authorised Because Class Communication Current Decision Draft Drug Drugs EPAR European Final From Health human Inc. Injection Issues medicines News Notice Possible Potential Press Product Products Public Recall Recalls Releases report Revision Risk Safety Shortages Solution Undeclared updated Voluntary

meds watch

© 2012 meds watch. All rights reserved. Premium WordPress Themes.